[Biclonal myeloma (IgG and IgA)].
作者信息
González Barón M, Martínez Fernández A, Durán A, Montero J M, Ordoñez A, Gasalla R
出版信息
Rev Clin Esp. 1973 Feb 28;128(4):345-8.
PMID:4700587
Abstract
摘要
相似文献
1
[Biclonal myeloma (IgG and IgA)].[双克隆骨髓瘤（IgG和IgA）]
Rev Clin Esp. 1973 Feb 28;128(4):345-8.
2
[A case of biclonal myeloma (IgG-IgA)].[一例双克隆骨髓瘤（IgG-IgA）]
Arch Maragliano Patol Clin. 1976;32:101-7.
3
4
[Myelomatous paraproteinemia of the IgA or IgG type and blood lipids].
Bull Soc Pathol Exot Filiales. 1974 Jan-Feb;67(1):101-8.
5
Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
Isr J Med Sci. 1977 Aug;13(8):797-807.
6
Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.单克隆IgD。60份含IgD“M”成分血清的比较研究。
Biomedicine. 1974 Mar 20;21(3):119-25.
7
[Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].伴有两种副蛋白（IgG κ和IgG λ）的单克隆浆细胞骨髓瘤
Nouv Presse Med. 1974 Dec 28;3(45):2707-11.
8
Gel filtration analysis of multiple myeloma sera.多发性骨髓瘤血清的凝胶过滤分析。
Haematologia (Budap). 1973;7(1):7-16.
9
Clinical classification of plasma cell myeloma.浆细胞骨髓瘤的临床分类
Arch Intern Med. 1975 Jan;135(1):139-43.
10
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.接受序贯治疗的本-周氏蛋白、IgG和IgA骨髓瘤新患者的比较：需要将这些免疫亚型视为具有特定预后标准的独立疾病实体。
Bone Marrow Transplant. 2001 Jul;28(1):29-37. doi: 10.1038/sj.bmt.1703093.
Zotero 插件